The absence of an increase in DTH and the weaker induction of an effective WT1-specific cellular immune response compared to the lung cancer group indicates that anti-tumor immunity is strongly suppressed in pancreatic cancer, which is consistent with previous knowledge [15,17,18]. The gene discussed is WT1; the disease is lung cancer.